Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I. van der Lee, Marieke Griffioen, J.H. Frederik Falkenburg et al.|Journal of Clinical Investigation|2019Cited by 232
Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of <i>ITGB2</i>Margot J. Pont, Marieke Griffioen, Dyantha I. van der Lee et al.|Clinical Cancer Research|2016Cited by 17
Supplemental Methods, Supplementary Figures 1-4, Supplementary Table 1 from Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of <i>ITGB2</i>Margot J. Pont, Marieke Griffioen, Dyantha I. van der Lee et al.|Unknown|2023Cited by 0
Data from Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of <i>ITGB2</i>Margot J. Pont, Marieke Griffioen, Dyantha I. van der Lee et al.|Unknown|2023Cited by 0
Data from Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of <i>ITGB2</i>Margot J. Pont, Marieke Griffioen, Dyantha I. van der Lee et al.|Unknown|2023Cited by 0